Top Medical Searches

Novo Nordisk’s diabetes drug succeeds in key trial

(Reuters) – Novo Nordisk A/S said on Wednesday its diabetes drug met the main goal of reducing glucose levels in patients in a key late-stage trial, setting the stage for it to become the new standard therapy for type 2 diabetes.

 Read more…

Be Sociable, Share!
August 17th, 2017 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us